sellWeak cluster of 210b5-1 plan

Martine A Rothblatt sold $5.5M of UTHR

Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $576.47, traded Oct 1, 2026, filed Oct 2, 2026.

Warning score

Value

$5.5M

9,500 shares

Holdings after

324,443

-3% from before

From 52-week low

+38%

low $415.34, close $571.38

From 52-week high

-4%

high $596.76, as of Oct 1, 2026

Score components

Role
CEO
+25
Trade size
$5.5M at market
+25
Share of holdings sold
Sold 2.8% of holdings
0
Cluster
2 insiders selling within 14 days
+8
Exercise and sell
Shares came from an option exercise in the same filing
-15
10b5-1 plan
Pre-scheduled under a 10b5-1 plan
-20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

UTHROct 9, 2026 · close 549.16

Since filing Oct 2, 2026: +1.4%SPY +1.2% · excess +0.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001106578-26-000155, as filed. Open on EDGAR

Date	Transaction	Shares	Price	Value	Holdings after	Filed
Oct 1, 2026	MOption exercise Common Stockindirect: by Trust10b5-1	+9,500	$117.76	$1.1M	333,943	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-120	$560.05	$67k	333,823	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-80	$561.68	$45k	333,743	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-160	$563.31	$90k	333,583	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-94	$567.90	$53k	333,489	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-306	$569.65	$174k	333,183	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-534	$570.55	$305k	332,649	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-320	$571.52	$183k	332,329	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-560	$572.86	$321k	331,769	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-280	$573.62	$161k	331,489	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-830	$574.94	$477k	330,659	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-1,346	$575.90	$775k	329,313	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-774	$576.91	$447k	328,539	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-930	$577.93	$537k	327,609	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-320	$579.02	$185k	327,289	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-864	$580.20	$501k	326,425	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-702	$581.21	$408k	325,723	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-520	$582.24	$303k	325,203	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-400	$583.28	$233k	324,803	10 d ago
Oct 1, 2026	SOpen-market sale Common Stockindirect: by Trust10b5-1	-360	$584.66	$210k	324,443	10 d ago
Oct 1, 2026	MOption exercise Stock Optionderivativeindirect: by Trust10b5-1	-9,500	$0.00	$0	318,910	10 d ago

Related signals

Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.

Score	Company	Insider	Value	Holdings	Filed
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$5.1M 9,500 shares	-3%	3 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$5.2M 9,500 shares	-3%	4 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$5.1M 9,500 shares	-3%	5 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$5.1M 9,500 shares	-3%	6 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$5.2M 9,500 shares	-3%	7 d ago
18Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Paul A Mahon EVP & GENERAL COUNSEL	$4.7M 8,300 shares	-16%	11 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$3.9M 7,580 shares	-2%	11 d ago
38Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$1.1M 1,920 shares	-1%	11 d ago
23Weak	UTHRsell 210b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$4.5M 9,500 shares	-3%	12 d ago
30Weak	UTHRsell 310b5-1 UNITED THERAPEUTICS Corp	Martine A Rothblatt Chairperson & CEO	$4.6M 9,500 shares	-3%	13 d ago

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.